Skip to main navigation

Technology & Pipeline
Medicines
Disease Overview
Investors
About Us
Careers
Menu

Investors

INVESTORS

Button link to Press Releases

Read More

Press Releases

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

Events & Presentations

Piper Sandler 36th Annual Healthcare Conference

Button link to Presentations

Read More

Button link to Financials and Filings

Read More

Financials & Filings

Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

Stock Information

Previous Close

Open

Volume

Exchange

52 Week High

52 Week Low

Minimum 15 minutes delayed. Source: LSEG

Shareholder Tools

Corporate Governance
Analyst Coverage
Email Alerts
Downloads
RSS News Feeds
Print
Share
Printed Materials
IR Search

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OK Privacy Policy Cookies Policy

Contact Us

X

Facebook
Google
LinkedIn
Twitter

© 2024 Intra-Cellular Therapies Inc. All rights reserved.

Copyrights Line Links

Term of Use
Privacy Policy
Cookies Policy
Site Map